|
Leader
|
|
|
00000nz a2200037n 45 0 |
|
001
|
|
|
WKP|Q100478508
(VIAF cluster)
(Authority/Source Record)
|
|
003
|
|
|
WKP |
|
005
|
|
|
20241221010624.0 |
|
008
|
|
|
241221nneanz||abbn n and d |
|
035
|
|
|
‡a
(WKP)Q100478508
|
|
024
|
|
|
‡a
0000-0002-1311-351X
‡2
orcid
|
|
024
|
|
|
‡a
0000-0001-8632-3633
‡2
orcid
|
|
035
|
|
|
‡a
(OCoLC)Q100478508
|
|
100
|
0 |
|
‡a
Dorothy J Becker
‡c
researcher
‡9
en
|
|
400
|
0 |
|
‡a
Dorothy J Becker
‡c
onderzoeker
‡9
nl
|
|
670
|
|
|
‡a
Author's 1-deamino-8-D-arginine vasopressin in the treatment of central diabetes insipidus in childhood
|
|
670
|
|
|
‡a
Author's A focus on blood glucose monitoring: relation to glycemic control and determinants of frequency
|
|
670
|
|
|
‡a
Author's A sero-epidemiologic study of nondiabetic first-degree relatives of IDDM cases
|
|
670
|
|
|
‡a
Author's Abnormal alpha cell hypoglycemic recognition in children with insulin dependent diabetes mellitus
|
|
670
|
|
|
‡a
Author's Abnormal alpha cell hypoglycemic recognition in children with insulin dependent diabetes mellitus (IDDM)
|
|
670
|
|
|
‡a
Author's Abnormal T-cell reactivities in childhood inflammatory demyelinating disease and type 1 diabetes.
|
|
670
|
|
|
‡a
Author's Age and sex variations in glucose tolerance and insulin responses: parallels with cardiovascular risk
|
|
670
|
|
|
‡a
Author's All-cause mortality trends in a large population-based cohort with long-standing childhood-onset type 1 diabetes: the Allegheny County type 1 diabetes registry
|
|
670
|
|
|
‡a
Author's Analyses on possible heterogeneity of IDDM based on presence of islet cell cytoplasmic antibody at diagnosis
|
|
670
|
|
|
‡a
Author's Antibodies to oxidized LDL and LDL-containing immune complexes as risk factors for coronary artery disease in diabetes mellitus
|
|
670
|
|
|
‡a
Author's Antibodies to oxidized LDL predict coronary artery disease in type 1 diabetes: a nested case-control study from the Pittsburgh Epidemiology of Diabetes Complications Study
|
|
670
|
|
|
‡a
Author's Antigen-based therapy with glutamic acid decarboxylase (GAD) vaccine in patients with recent-onset type 1 diabetes: a randomised double-blind trial
|
|
670
|
|
|
‡a
Author's Are predictors of coronary heart disease and lower-extremity arterial disease in type 1 diabetes the same? A prospective study
|
|
670
|
|
|
‡a
Author's Assessment of AlbuSure and its usefulness in identifying IDDM subjects at increased risk for developing clinical diabetic nephropathy
|
|
670
|
|
|
‡a
Author's Association between family history, early growth and the risk of beta cell autoimmunity in children at risk for type 1 diabetes
|
|
670
|
|
|
‡a
Author's Associations of HbA1c with the timing of C-peptide responses during the oral glucose tolerance test at the diagnosis of type 1 diabetes
|
|
670
|
|
|
‡a
Author's Autoantibodies Directed Toward a Novel IA-2 Variant Protein Enhance Prediction of Type 1 Diabetes
|
|
670
|
|
|
‡a
Author's Autoimmune islet destruction in spontaneous type 1 diabetes is not beta-cell exclusive.
|
|
670
|
|
|
‡a
Author's Autoimmunity and genetics contribute to the risk of insulin-dependent diabetes mellitus in families: islet cell antibodies and HLA DQ heterodimers
|
|
670
|
|
|
‡a
Author's B-lymphocyte depletion with rituximab and β-cell function: two-year results
|
|
670
|
|
|
‡a
Author's Breastfeeding patterns of mothers with type 1 diabetes: results from an infant feeding trial
|
|
670
|
|
|
‡a
Author's Brief report: trajectories of glycemic control over early to middle adolescence
|
|
670
|
|
|
‡a
Author's Can management strategies alter the course of diabetic nephropathy?
|
|
670
|
|
|
‡a
Author's Cardiovascular disease and arterial calcification in insulin-dependent diabetes mellitus: interrelations and risk factor profiles. Pittsburgh Epidemiology of Diabetes Complications Study-V
|
|
670
|
|
|
‡a
Author's Cause-specific mortality trends in a large population-based cohort with long-standing childhood-onset type 1 diabetes
|
|
670
|
|
|
‡a
Author's Celiac Autoimmunity Is Associated With Lower Blood Pressure and Renal Risk in Type 1 Diabetes
|
|
670
|
|
|
‡a
Author's Changes in glycaemic control and risk of coronary artery disease in type 1 diabetes mellitus: findings from the Pittsburgh Epidemiology of Diabetes Complications Study (EDC).
|
|
670
|
|
|
‡a
Author's Changing impact of modifiable risk factors on the incidence of major outcomes of type 1 diabetes: the Pittsburgh Epidemiology of Diabetes Complications Study
|
|
670
|
|
|
‡a
Author's Changing Prevalence of Overweight Children and Adolescents at Onset of Insulin-Treated Diabetes
|
|
670
|
|
|
‡a
Author's Characteristics of slow progression to diabetes in multiple islet autoantibody-positive individuals from five longitudinal cohorts: the SNAIL study.
|
|
670
|
|
|
‡a
Author's Characterization of Somatostatin Specific Binding in Plasma Cell Membranes of Human Placenta
|
|
670
|
|
|
‡a
Author's Characterizing sudden death and dead-in-bed syndrome in Type 1 diabetes: analysis from two childhood-onset Type 1 diabetes registries.
|
|
670
|
|
|
‡a
Author's Choice of urine sample predictive of microalbuminuria in patients with insulin-dependent diabetes mellitus
|
|
670
|
|
|
‡a
Author's Clustering of premature mortality in 1,761 insulin-dependent diabetics and their family members
|
|
670
|
|
|
‡a
Author's Co-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled trial
|
|
670
|
|
|
‡a
Author's Coexistence of type 1 and type 2 diabetes mellitus: "double" diabetes?
|
|
670
|
|
|
‡a
Author's Cognitive adaptation theory as a predictor of adjustment to emerging adulthood for youth with and without type 1 diabetes
|
|
670
|
|
|
‡a
Author's Combined analysis of GAD65 and ICA512
|
|
670
|
|
|
‡a
Author's Combined analysis of GAD65 and ICA512(IA-2) autoantibodies in organ and non-organ-specific autoimmune diseases confers high specificity for insulin-dependent diabetes mellitus
|
|
670
|
|
|
‡a
Author's Comparison of adolescents with and without diabetes on indices of psychosocial functioning for three years
|
|
670
|
|
|
‡a
Author's Comparison of Physiologic and Pharmacologic Assessment of Growth Hormone Secretion
|
|
670
|
|
|
‡a
Author's Condom use, pregnancy, and STDs in adolescent females with and without type 1 diabetes.
|
|
670
|
|
|
‡a
Author's Contribution of diabetes duration before puberty to development of microvascular complications in IDDM subjects
|
|
670
|
|
|
‡a
Author's Coronary artery disease in IDDM. Gender differences in risk factors but not risk
|
|
670
|
|
|
‡a
Author's Coronary calcium in adults with type 1 diabetes: a stronger correlate of clinical coronary artery disease in men than in women
|
|
670
|
|
|
‡a
Author's Correlates of insulin antibodies in newly diagnosed children with insulin-dependent diabetes before insulin therapy
|
|
670
|
|
|
‡a
Author's Costimulation modulation with abatacept in patients with recent-onset type 1 diabetes: follow-up 1 year after cessation of treatment
|
|
670
|
|
|
‡a
Author's Cross-sectional and longitudinal relationship of sodium-lithium countertransport to insulin, obesity and blood pressure in healthy perimenopausal women
|
|
670
|
|
|
‡a
Author's Cumulative glycemic exposure and microvascular complications in insulin-dependent diabetes mellitus. The glycemic threshold revisited
|
|
670
|
|
|
‡a
Author's Cyclosporin therapy for prevention and cure of IDDM. Epidemiological perspective of benefits and risks
|
|
670
|
|
|
‡a
Author's Cytoplasmic islet cell antibodies remain valuable in defining risk of progression to type 1 diabetes in subjects with other islet autoantibodies.
|
|
670
|
|
|
‡a
Author's Demonstration of a dawn phenomenon in normal adolescents
|
|
670
|
|
|
‡a
Author's Detection of symptoms by adolescents and young adults with type 1 diabetes during experimental induction of mild hypoglycemia: role of hormonal and psychological variables.
|
|
670
|
|
|
‡a
Author's Diabetes complications and glycemic control. The Pittsburgh Prospective Insulin-Dependent Diabetes Cohort Study Status Report after 5 yr of IDDM
|
|
670
|
|
|
‡a
Author's Diabetic autonomic neuropathy and cardiovascular risk. Pittsburgh Epidemiology of Diabetes Complications Study III
|
|
670
|
|
|
‡a
Author's Diabetic nephropathy in adolescence: appearance during improved glycemic control
|
|
670
|
|
|
‡a
Author's Diabetic retinopathy in Mauriac's syndrome. Paradoxical deterioration with improved metabolic control
|
|
670
|
|
|
‡a
Author's Diet of adolescents with and without diabetes: Trading candy for potato chips?
|
|
670
|
|
|
‡a
Author's Differences between blacks and whites in the epidemiology of insulin-dependent diabetes mellitus in Allegheny County, Pennsylvania
|
|
670
|
|
|
‡a
Author's Disease progression among 446 children with newly diagnosed type 1 diabetes located in Scandinavia, Europe, and North America during the last 27 yr
|
|
670
|
|
|
‡a
Author's Diurnal glucose--dependent fluctuations in glycosylated hemoglobin levels in insulin-dependent diabetes
|
|
670
|
|
|
‡a
Author's Early adolescent relationship predictors of emerging adult outcomes: youth with and without type 1 diabetes
|
|
670
|
|
|
‡a
Author's Early and late C-peptide responses during oral glucose tolerance testing are oppositely predictive of type 1 diabetes in autoantibody-positive individuals
|
|
670
|
|
|
‡a
Author's Early feeding and risk of type 1 diabetes: experiences from the Trial to Reduce Insulin-dependent diabetes mellitus in the Genetically at Risk (TRIGR).
|
|
670
|
|
|
‡a
Author's Editorial Tribute: Mark A. Sperling, MD, Editor-in-Chief, Pediatric Diabetes 2000-2017
|
|
670
|
|
|
‡a
Author's Effect of Hydrolyzed Infant Formula vs Conventional Formula on Risk of Type 1 Diabetes: The TRIGR Randomized Clinical Trial
|
|
670
|
|
|
‡a
Author's Effects of enhanced conventional therapy on metabolic control in children with insulin-dependent diabetes mellitus
|
|
670
|
|
|
‡a
Author's Effects of improved glycemic control on microalbuminuria in adolescents with insulin-dependent diabetes mellitus
|
|
670
|
|
|
‡a
Author's Electroencephalographic changes in diabetic ketosis in children with newly and previously diagnosed insulin-dependent diabetes mellitus
|
|
670
|
|
|
‡a
Author's Emerging adults with type 1 diabetes: a comparison to peers without diabetes
|
|
670
|
|
|
‡a
Author's Employment patterns among parents of children with insulin-dependent diabetes mellitus (IDDM)
|
|
670
|
|
|
‡a
Author's Employment spectrum of IDDM
|
|
670
|
|
|
‡a
Author's Epidemiological correlates of diabetic neuropathy. Report from Pittsburgh Epidemiology of Diabetes Complications Study
|
|
670
|
|
|
‡a
Author's Epidemiology, pathophysiology, and prognostic implications of cystic fibrosis-related diabetes: a technical review
|
|
670
|
|
|
‡a
Author's Evidence for heterogeneous pathogenesis of insulin-treated diabetes in black and white children
|
|
670
|
|
|
‡a
Author's Evolution of the Pittsburgh studies of the epidemiology of insulin-dependent diabetes mellitus. Pittsburgh Diabetes Epidemiology and Etiology Research Group
|
|
670
|
|
|
‡a
Author's Excess BMI Accelerates Islet Autoimmunity in Older Children and Adolescents
|
|
670
|
|
|
‡a
Author's Excess BMI in Childhood: A Modifiable Risk Factor for Type 1 Diabetes Development?
|
|
670
|
|
|
‡a
Author's Factors affecting glycosylated hemoglobin values in children with insulin-dependent diabetes
|
|
670
|
|
|
‡a
Author's Factors associated with avoidance of severe complications after 25 yr of IDDM. Pittsburgh Epidemiology of Diabetes Complications Study I.
|
|
670
|
|
|
‡a
Author's Familial and sporadic insulin-dependent diabetes: evidence for heterogeneous etiologies?
|
|
670
|
|
|
‡a
Author's Familial insulin-dependent diabetes mellitus and hemipancreatectomy
|
|
670
|
|
|
‡a
Author's Families with children with diabetes: implications of parent stress for parent and child health
|
|
670
|
|
|
‡a
Author's Featured Article: Trajectories of Glycemic Control Over Adolescence and Emerging Adulthood: An 11-Year Longitudinal Study of Youth With Type 1 Diabetes
|
|
670
|
|
|
‡a
Author's Friendship and romantic relationships among emerging adults with and without type 1 diabetes
|
|
670
|
|
|
‡a
Author's Future intervention trials in type 1 diabetes
|
|
670
|
|
|
‡a
Author's Glucagon responses to hypoglycemia in children and adolescents with IDDM
|
|
670
|
|
|
‡a
Author's Glucose control in Rwandan youth with type 1 diabetes following establishment of systematic, HbA1c based, care and education
|
|
670
|
|
|
‡a
Author's Glucose tolerance in siblings of type 1 diabetic patients: relationship to HLA status
|
|
670
|
|
|
‡a
Author's Glycemia (or, in women, estimated glucose disposal rate) predict lower extremity arterial disease events in type 1 diabetes
|
|
670
|
|
|
‡a
Author's Glycosylated haemoglobin in children with insulin-dependent diabetes mellitus
|
|
670
|
|
|
‡a
Author's Glycosylated hemoglobin: a screening test for diabetes mellitus?
|
|
670
|
|
|
‡a
Author's Growth differences between North American and European children at risk for type 1 diabetes
|
|
670
|
|
|
‡a
Author's Growth hormone therapy and tumor recurrence. Findings in children with brain neoplasms and hypopituitarism
|
|
670
|
|
|
‡a
Author's Growth hormone therapy for patients with Turner's syndrome
|
|
670
|
|
|
‡a
Author's Health insurance and the financial impact of IDDM in families with a child with IDDM.
|
|
670
|
|
|
‡a
Author's Health, life, and automobile insurance characteristics in adults with IDDM.
|
|
670
|
|
|
‡a
Author's Height at diagnosis of insulin dependent diabetes in patients and their non-diabetic family members
|
|
670
|
|
|
‡a
Author's HLA-DRB1*15:01-DQA1*01:02-DQB1*06:02 Haplotype Protects Autoantibody-Positive Relatives From Type 1 Diabetes Throughout the Stages of Disease Progression
|
|
670
|
|
|
‡a
Author's HLA heterogeneity of insulin-dependent diabetes mellitus at diagnosis. The Pittsburgh IDDM study
|
|
670
|
|
|
‡a
Author's Hormonal, metabolic, and neuroradiologic abnormalities associated with septo-optic dysplasia
|
|
670
|
|
|
‡a
Author's Human insulin use and hypoglycaemia: insights from the Pittsburgh Epidemiology of Diabetes Complications Study
|
|
670
|
|
|
‡a
Author's Humoral autoimmunity against the extracellular domain of the neuroendocrine autoantigen IA-2 heightens the risk of type 1 diabetes
|
|
670
|
|
|
‡a
Author's Hydrolyzed infant formula and early β-cell autoimmunity: a randomized clinical trial
|
|
670
|
|
|
‡a
Author's Hypertension as a risk factor for diabetic neuropathy: a prospective study
|
|
670
|
|
|
‡a
Author's Hypoglycemia: a complication of diabetes therapy in children
|
|
670
|
|
|
‡a
Author's Hypoplasia of the pancreas in a patient with type I diabetes mellitus
|
|
670
|
|
|
‡a
Author's Impact of a preconception counseling program for teens with type 1 diabetes (READY-Girls) on patient-provider interaction, resource utilization, and cost
|
|
670
|
|
|
‡a
Author's Impact of Age and Antibody Type on Progression From Single to Multiple Autoantibodies in Type 1 Diabetes Relatives
|
|
670
|
|
|
‡a
Author's Impaired counterregulatory hormone responses to hypoglycemia in children and adolescents with new onset IDDM
|
|
670
|
|
|
‡a
Author's Incidence of ESRD and survival after renal replacement therapy in patients with type 1 diabetes: a report from the Allegheny County Registry
|
|
670
|
|
|
‡a
Author's Increased Expression of Monocyte CD11b (Mac-1) in Overweight Recent-Onset Type 1 Diabetic Children
|
|
670
|
|
|
‡a
Author's Infant feeding and autoimmune diabetes.
|
|
670
|
|
|
‡a
Author's Infant Feeding and Timing of Complementary Foods in the Development of Type 1 Diabetes.
|
|
670
|
|
|
‡a
Author's Insulin as a predictor of coronary heart disease: interaction with apolipoprotein E phenotype. A report from the Multiple Risk Factor Intervention Trial
|
|
670
|
|
|
‡a
Author's Insulin-dependent diabetes mellitus mortality. The risk of cigarette smoking
|
|
670
|
|
|
‡a
Author's Insulin-dependent diabetes mellitus, physical activity, and death
|
|
670
|
|
|
‡a
Author's Insulin resistance-related factors, but not glycemia, predict coronary artery disease in type 1 diabetes: 10-year follow-up data from the Pittsburgh Epidemiology of Diabetes Complications Study
|
|
670
|
|
|
‡a
Author's Intensive diabetes therapy in childhood: is it achievable? Is it desirable? Is it safe?
|
|
670
|
|
|
‡a
Author's Interleukin-1 antagonism in type 1 diabetes of recent onset: two multicentre, randomised, double-blind, placebo-controlled trials
|
|
670
|
|
|
‡a
Author's Introducing the Endotype Concept to Address the Challenge of Disease Heterogeneity in Type 1 Diabetes
|
|
670
|
|
|
‡a
Author's ISPAD Clinical Practice Consensus Guidelines 2014. Management of cystic fibrosis-related diabetes in children and adolescents
|
|
670
|
|
|
‡a
Author's ISPAD Clinical Practice Consensus Guidelines 2018: Management of cystic fibrosis-related diabetes in children and adolescents
|
|
670
|
|
|
‡a
Author's Knowledge, attitudes and behaviors related to sexuality and family planning in adolescent women with and without diabetes
|
|
670
|
|
|
‡a
Author's Large-scale prospective T cell function assays in shipped, unfrozen blood samples: experiences from the multicenter TRIGR trial
|
|
670
|
|
|
‡a
Author's Leptin before and after insulin therapy in children with new-onset type 1 diabetes
|
|
670
|
|
|
‡a
Author's Lipid and blood pressure treatment goals for type 1 diabetes: 10-year incidence data from the Pittsburgh Epidemiology of Diabetes Complications Study
|
|
670
|
|
|
‡a
Author's Lipoprotein(a) concentration shows little relationship to IDDM complications in the Pittsburgh Epidemiology of Diabetes Complications Study cohort
|
|
670
|
|
|
‡a
Author's Long-term effects of the booster-enhanced READY-Girls preconception counseling program on intentions and behaviors for family planning in teens with diabetes
|
|
670
|
|
|
‡a
Author's Low-Dose Anti-Thymocyte Globulin
|
|
670
|
|
|
‡a
Author's Low-Dose Anti-Thymocyte Globulin (ATG) Preserves β-Cell Function and Improves HbA in New-Onset Type 1 Diabetes
|
|
670
|
|
|
‡a
Author's Low-Dose Anti-Thymocyte Globulin Preserves C-Peptide, Reduces HbA1c, and Increases Regulatory to Conventional T-Cell Ratios in New-Onset Type 1 Diabetes: Two-Year Clinical Trial Data
|
|
670
|
|
|
‡a
Author's Measuring diabetic neuropathy. Assessment and comparison of clinical examination and quantitative sensory testing
|
|
670
|
|
|
‡a
Author's Measuring subclinical neuropathy: does it relate to clinical neuropathy? Pittsburgh epidemiology of diabetes complications study-V
|
|
670
|
|
|
‡a
Author's Mother-daughter dyadic approach for starting preconception counseling at puberty in girls with diabetes
|
|
670
|
|
|
‡a
Author's Motor vehicle accidents and IDDM
|
|
670
|
|
|
‡a
Author's Multivariate analyses of the risk of insulin-dependent diabetes mellitus for siblings of insulin-dependent diabetic patients
|
|
670
|
|
|
‡a
Author's Need for genetic education for type 1 diabetes
|
|
670
|
|
|
‡a
Author's Neuronal T-cell autoreactivity is amplified in overweight children with new-onset insulin-requiring diabetes.
|
|
670
|
|
|
‡a
Author's Obesity, islet cell autoimmunity, and cardiovascular risk factors in youth at onset of type 1 autoimmune diabetes
|
|
670
|
|
|
‡a
Author's Older age of childhood type 1 diabetes onset is associated with islet autoantibody positivity >30 years later: the Pittsburgh Epidemiology of Diabetes Complications Study
|
|
670
|
|
|
‡a
Author's Operationalizing and Examining Family Planning Vigilance in Adult Women With Type 1 Diabetes
|
|
670
|
|
|
‡a
Author's Parent and adolescent distribution of responsibility for diabetes self-care: links to health outcomes
|
|
670
|
|
|
‡a
Author's Peptide dose, MHC affinity, and target self-antigen expression are critical for effective immunotherapy of nonobese diabetic mouse prediabetes
|
|
670
|
|
|
‡a
Author's Persistent C-peptide levels and microvascular complications in childhood onset type 1 diabetes of long duration
|
|
670
|
|
|
‡a
Author's Persistent T cell anergy in human type 1 diabetes.
|
|
670
|
|
|
‡a
Author's Phosphate replacement during treatment of diabetic ketosis. Effects on calcium and phosphorus homeostasis
|
|
670
|
|
|
‡a
Author's Physical activity, insulin sensitivity, and the lipoprotein profile in young adults: the Beaver County Study
|
|
670
|
|
|
‡a
Author's PHYSICIANS' SELF-PERCEPTIONS OF CARE FOR EMERGING ADULTS WITH TYPE 1 DIABETES.
|
|
670
|
|
|
‡a
Author's Pittsburgh Epidemiology of Diabetes Complications Study. Measuring diabetic neuropathy follow-up study results
|
|
670
|
|
|
‡a
Author's Pittsburgh Insulin-Dependent Diabetes Mellitus Morbidity and Mortality Study: physical activity and diabetic complications
|
|
670
|
|
|
‡a
Author's Plasma catecholamine responses to hypoglycemia in children and adolescents with IDDM
|
|
670
|
|
|
‡a
Author's Plasma insulin and lipoprotein concentrations: an atherogenic association?
|
|
670
|
|
|
‡a
Author's Poisson regression modeling of temporal variation in incidence of childhood insulin-dependent diabetes mellitus in Allegheny County, Pennsylvania, and Wielkopolska, Poland, 1970-1985.
|
|
670
|
|
|
‡a
Author's Predictors of metabolic control among adolescents with diabetes: a 4-year longitudinal study
|
|
670
|
|
|
‡a
Author's Predictors of microalbuminuria in individuals with IDDM. Pittsburgh Epidemiology of Diabetes Complications Study
|
|
670
|
|
|
‡a
Author's Prevalence and incidence of clinically recognized cases of Type 1 diabetes in children and adolescents in Rwanda, Africa.
|
|
670
|
|
|
‡a
Author's Prevalence of complications in IDDM by sex and duration. Pittsburgh Epidemiology of Diabetes Complications Study II
|
|
670
|
|
|
‡a
Author's Progression to insulin-requiring diabetes in seronegative prediabetic subjects: the role of two HLA-DQ high-risk haplotypes
|
|
670
|
|
|
‡a
Author's Progressive erosion of β-cell function precedes the onset of hyperglycemia in the NOD mouse model of type 1 diabetes
|
|
670
|
|
|
‡a
Author's Progressive retinopathy with improved control in diabetic dwarfism
|
|
670
|
|
|
‡a
Author's Progressive retinopathy with improved control in diabetic dwarfism (Mauriac's syndrome)
|
|
670
|
|
|
‡a
Author's Proteinuria in children with insulin-dependent diabetes: relationship to duration of disease, metabolic control, and retinal changes
|
|
670
|
|
|
‡a
Author's Psychosocial correlates of glycemic control: the Pittsburgh Epidemiology of Diabetes Complications
|
|
670
|
|
|
‡a
Author's Psychosocial correlates of glycemic control: the Pittsburgh Epidemiology of Diabetes Complications (EDC) Study
|
|
670
|
|
|
‡a
Author's Psychosocial predictors of diabetes risk factors and complications: An 11-year follow-up
|
|
670
|
|
|
‡a
Author's Randomized efficacy trial of early preconception counseling for diabetic teens (READY-girls).
|
|
670
|
|
|
‡a
Author's Regional cerebral blood flow during hypoglycaemia in children with IDDM
|
|
670
|
|
|
‡a
Author's Regional differences in milk and complementary feeding patterns in infants participating in an international nutritional type 1 diabetes prevention trial
|
|
670
|
|
|
‡a
Author's Relation of parent knowledge to glycemic control among emerging adults with type 1 diabetes: a mediational model
|
|
670
|
|
|
‡a
Author's Relation of stressful life events to metabolic control among adolescents with diabetes: 5-year longitudinal study
|
|
670
|
|
|
‡a
Author's Relations of behavioral autonomy to health outcomes among emerging adults with and without type 1 diabetes
|
|
670
|
|
|
‡a
Author's Relationship of adiponectin and leptin with autoimmunity in children with new-onset type 1 diabetes: a pilot study
|
|
670
|
|
|
‡a
Author's Relationships and health among emerging adults with and without Type 1 diabetes.
|
|
670
|
|
|
‡a
Author's Residual beta-cell function in children with IDDM: reproducibility of testing and factors influencing insulin secretory reserve
|
|
670
|
|
|
‡a
Author's Rituximab, B-Lymphocyte Depletion, and Preservation of Beta-Cell Function
|
|
670
|
|
|
‡a
Author's Screening, staging, and naming of presymptomatic type 1 diabetes.
|
|
670
|
|
|
‡a
Author's Sex differences in diabetes
|
|
670
|
|
|
‡a
Author's Sex differences in secondary attack rate of IDDM to siblings of probands through older ages. Pittsburgh Etiology of IDDM Study
|
|
670
|
|
|
‡a
Author's Sex differences in the coronary heart disease risk profile: a possible role for insulin. The Beaver County Study
|
|
670
|
|
|
‡a
Author's Sexual dimorphism in insulin sensitivity in adolescents with insulin-dependent diabetes mellitus.
|
|
670
|
|
|
‡a
Author's Single Islet Autoantibody at Diagnosis of Clinical Type 1 Diabetes is Associated With Older Age and Insulin Resistance
|
|
670
|
|
|
‡a
Author's Sodium-lithium countertransport activity is decreased after weight loss in healthy obese men.
|
|
670
|
|
|
‡a
Author's Spontaneous whole blood platelet aggregation, hematological variables and complications in insulin-dependent diabetes mellitus: the Pittsburgh Epidemiology of Diabetes Complications Study
|
|
670
|
|
|
‡a
Author's Subclinical atherosclerosis and estimated glucose disposal rate as predictors of mortality in type 1 diabetes
|
|
670
|
|
|
‡a
Author's T cells of multiple sclerosis patients target a common environmental peptide that causes encephalitis in mice
|
|
670
|
|
|
‡a
Author's Targeting of pancreatic glia in type 1 diabetes.
|
|
670
|
|
|
‡a
Author's The 30-year natural history of type 1 diabetes complications: the Pittsburgh Epidemiology of Diabetes Complications Study experience
|
|
670
|
|
|
‡a
Author's The association between a family history of type 2 diabetes and coronary artery disease in a type 1 diabetes population
|
|
670
|
|
|
‡a
Author's The association of waist/hip ratio with diabetes complications in an adult IDDM population
|
|
670
|
|
|
‡a
Author's The cardiovascular risk profile of adolescents with insulin-dependent diabetes mellitus
|
|
670
|
|
|
‡a
Author's The changing course of diabetic nephropathy: low-density lipoprotein cholesterol and blood pressure correlate with regression of proteinuria.
|
|
670
|
|
|
‡a
Author's The Dawn Phenomenon: Comparison between Normal and Insulin-Dependent Diabetic Adolescents
|
|
670
|
|
|
‡a
Author's The development of Type 1
|
|
670
|
|
|
‡a
Author's The development of Type 1 (insulin-dependent) diabetes mellitus: two contrasting presentations
|
|
670
|
|
|
‡a
Author's The effect of age on insulin sensitivity and insulin secretion in first-degree relatives of type 1 diabetic patients: a population analysis
|
|
670
|
|
|
‡a
Author's The effect of cyproheptadine and human growth hormone on adrenocortical function in children with hypopituitarism
|
|
670
|
|
|
‡a
Author's The effects of water deprivation and water loading during treatment with 1-deamino-8-D-arginine vasopressin in central diabetes insipidus in childhood
|
|
670
|
|
|
‡a
Author's [The epidemiology and etiology of insulin dependent diabetes mellitus in the child]
|
|
670
|
|
|
‡a
Author's The epidemiology of diabetes complications study. IV. Correlates of diabetic background and proliferative retinopathy
|
|
670
|
|
|
‡a
Author's The impact of the apolipoprotein E polymorphism on the lipoprotein profile in insulin-dependent diabetes: the Pittsburgh Epidemiology of Diabetes Complications Study IX.
|
|
670
|
|
|
‡a
Author's The interface between epidemiology and molecular biology in the search for the causes of insulin-dependent diabetes mellitus
|
|
670
|
|
|
‡a
Author's The investigation of age at onset as a risk factor for mortality in persons with insulin-dependent diabetes mellitus using Cox proportional hazards models
|
|
670
|
|
|
‡a
Author's The natural history of diabetes complications: the Pittsburgh studies
|
|
670
|
|
|
‡a
Author's The Pathological Evolution of Glucose Response Curves During the Progression to Type 1 Diabetes in the TrialNet Pathway to Prevention Study
|
|
670
|
|
|
‡a
Author's The Pittsburgh Insulin-Dependent Diabetes Mellitus
|
|
670
|
|
|
‡a
Author's The Pittsburgh Insulin-Dependent Diabetes Mellitus (IDDM) Morbidity and Mortality Study: case-control analyses of risk factors for mortality
|
|
670
|
|
|
‡a
Author's The Pittsburgh insulin-dependent diabetes mellitus (IDDM) morbidity and mortality study. Mortality results
|
|
670
|
|
|
‡a
Author's The Pittsburgh Insulin-Dependent Diabetes Mellitus (IDDM) study. HLA antigens and haplotypes as risk factors for the development of IDDM in IDDM patients and their siblings
|
|
670
|
|
|
‡a
Author's The progression of retinopathy over 2 years: the Pittsburgh Epidemiology of Diabetes Complications
|
|
670
|
|
|
‡a
Author's The progression of retinopathy over 2 years: the Pittsburgh Epidemiology of Diabetes Complications (EDC) Study
|
|
670
|
|
|
‡a
Author's The Role of Age and Excess Body Mass Index in Progression to Type 1 Diabetes in At-Risk Adults
|
|
670
|
|
|
‡a
Author's The role of friendship in the lives of male and female adolescents: does diabetes make a difference?
|
|
670
|
|
|
‡a
Author's The shape of the glucose concentration curve during an oral glucose tolerance test predicts risk for type 1 diabetes
|
|
670
|
|
|
‡a
Author's The TRIGR Trial: Testing the Potential Link between Weaning Diet and Type 1 Diabetes
|
|
670
|
|
|
‡a
Author's Therapeutic controversy: prevention and treatment of diabetes in children
|
|
670
|
|
|
‡a
Author's Thyroid autoimmunity in children with features of both type 1 and type 2 diabetes.
|
|
670
|
|
|
‡a
Author's Transfer from pediatric to adult health care: effects on diabetes outcomes.
|
|
670
|
|
|
‡a
Author's Trials without placebo controls in pre-IDDM: a complex and difficult issue
|
|
670
|
|
|
‡a
Author's Type 1 diabetes intervention trials
|
|
670
|
|
|
‡a
Author's Type I diabetes and multiple sclerosis patients target islet plus central nervous system autoantigens; nonimmunized nonobese diabetic mice can develop autoimmune encephalitis.
|
|
670
|
|
|
‡a
Author's Unmitigated communion and health among adolescents with and without diabetes: the mediating role of eating disturbances
|
|
670
|
|
|
‡a
Author's Use of vitamin D supplements during infancy in an international feeding trial
|
|
909
|
|
|
‡a
(orcid) 000000021311351x
‡9
1
|
|
909
|
|
|
‡a
(orcid) 0000000186323633
‡9
1
|
|
919
|
|
|
‡a
combinedanalysisofgad65andica512
‡A
Combined analysis of GAD65 and ICA512
‡9
1
|
|
919
|
|
|
‡a
cognitiveadaptationtheoryasapredictorofadjustmenttoemergingadulthoodforyouthwithandwithouttype1diabetes
‡A
Cognitive adaptation theory as a predictor of adjustment to emerging adulthood for youth with and without type 1 diabetes
‡9
1
|
|
919
|
|
|
‡a
breastfeedingpatternsofmotherswithtype1diabetesresultsfromaninfantfeedingtrial
‡A
Breastfeeding patterns of mothers with type 1 diabetes: results from an infant feeding trial
‡9
1
|
|
919
|
|
|
‡a
useofvitamin500supplementsduringinfancyinaninternationalfeedingtrial
‡A
Use of vitamin D supplements during infancy in an international feeding trial
‡9
1
|
|
919
|
|
|
‡a
unmitigatedcommunionandhealthamongadolescentswithandwithoutdiabetesthemediatingroleofeatingdisturbances
‡A
Unmitigated communion and health among adolescents with and without diabetes: the mediating role of eating disturbances
‡9
1
|
|
919
|
|
|
‡a
briefreporttrajectoriesofglycemiccontroloverearlytomiddleadolescence
‡A
Brief report: trajectories of glycemic control over early to middle adolescence
‡9
1
|
|
919
|
|
|
‡a
canmanagementstrategiesalterthecourseofdiabeticnephropathy
‡A
Can management strategies alter the course of diabetic nephropathy?
‡9
1
|
|
919
|
|
|
‡a
type1diabetesandmultiplesclerosispatientstargetisletpluscentralnervoussystemautoantigensnonimmunizednonobesediabeticmicecandevelopautoimmuneencephalitis
‡A
Type I diabetes and multiple sclerosis patients target islet plus central nervous system autoantigens; nonimmunized nonobese diabetic mice can develop autoimmune encephalitis.
‡9
1
|
|
919
|
|
|
‡a
type1diabetesinterventiontrials
‡A
Type 1 diabetes intervention trials
‡9
1
|
|
919
|
|
|
‡a
cardiovasculardiseaseandarterialcalcificationininsulindependentdiabetesmellitusinterrelationsandriskfactorprofilespittsburghepidemiologyofdiabetescomplicationsstudy5
‡A
Cardiovascular disease and arterial calcification in insulin-dependent diabetes mellitus: interrelations and risk factor profiles. Pittsburgh Epidemiology of Diabetes Complications Study-V
‡9
1
|
|
919
|
|
|
‡a
trialswithoutplacebocontrolsinpreiddmacomplexanddifficultissue
‡A
Trials without placebo controls in pre-IDDM: a complex and difficult issue
‡9
1
|
|
919
|
|
|
‡a
transferfrompediatrictoadulthealthcareeffectsondiabetesoutcomes
‡A
Transfer from pediatric to adult health care: effects on diabetes outcomes.
‡9
1
|
|
919
|
|
|
‡a
thyroidautoimmunityinchildrenwithfeaturesofbothtype1andtype2diabetes
‡A
Thyroid autoimmunity in children with features of both type 1 and type 2 diabetes.
‡9
1
|
|
919
|
|
|
‡a
causespecificmortalitytrendsinalargepopulationbasedcohortwithlongstandingchildhoodonsettype1diabetes
‡A
Cause-specific mortality trends in a large population-based cohort with long-standing childhood-onset type 1 diabetes
‡9
1
|
|
919
|
|
|
‡a
therapeuticcontroversypreventionandtreatmentofdiabetesinchildren
‡A
Therapeutic controversy: prevention and treatment of diabetes in children
‡9
1
|
|
919
|
|
|
‡a
trigrtrialtestingthepotentiallinkbetweenweaningdietandtype1diabetes
‡A
The TRIGR Trial: Testing the Potential Link between Weaning Diet and Type 1 Diabetes
‡9
1
|
|
919
|
|
|
‡a
shapeoftheglucoseconcentrationcurveduringanoralglucosetolerancetestpredictsriskfortype1diabetes
‡A
The shape of the glucose concentration curve during an oral glucose tolerance test predicts risk for type 1 diabetes
‡9
1
|
|
919
|
|
|
‡a
roleoffriendshipinthelivesofmaleandfemaleadolescentsdoesdiabetesmakeadifference
‡A
The role of friendship in the lives of male and female adolescents: does diabetes make a difference?
‡9
1
|
|
919
|
|
|
‡a
roleofageandexcessbodymassindexinprogressiontotype1diabetesinatriskadults
‡A
The Role of Age and Excess Body Mass Index in Progression to Type 1 Diabetes in At-Risk Adults
‡9
1
|
|
919
|
|
|
‡a
progressionofretinopathyover2yearsthepittsburghepidemiologyofdiabetescomplicationsedcstudy
‡A
The progression of retinopathy over 2 years: the Pittsburgh Epidemiology of Diabetes Complications (EDC) Study
‡9
1
|
|
919
|
|
|
‡a
progressionofretinopathyover2yearsthepittsburghepidemiologyofdiabetescomplications
‡A
The progression of retinopathy over 2 years: the Pittsburgh Epidemiology of Diabetes Complications
‡9
1
|
|
919
|
|
|
‡a
pittsburghinsulindependentdiabetesmellitusiddmstudyhlaantigensandhaplotypesasriskfactorsforthedevelopmentofiddminiddmpatientsandtheirsiblings
‡A
The Pittsburgh Insulin-Dependent Diabetes Mellitus (IDDM) study. HLA antigens and haplotypes as risk factors for the development of IDDM in IDDM patients and their siblings
‡9
1
|
|
919
|
|
|
‡a
pittsburghinsulindependentdiabetesmellitusiddmmorbidityandmortalitystudymortalityresults
‡A
The Pittsburgh insulin-dependent diabetes mellitus (IDDM) morbidity and mortality study. Mortality results
‡9
1
|
|
919
|
|
|
‡a
pittsburghinsulindependentdiabetesmellitusiddmmorbidityandmortalitystudycasecontrolanalysesofriskfactorsformortality
‡A
The Pittsburgh Insulin-Dependent Diabetes Mellitus (IDDM) Morbidity and Mortality Study: case-control analyses of risk factors for mortality
‡9
1
|
|
919
|
|
|
‡a
pittsburghinsulindependentdiabetesmellitus
‡A
The Pittsburgh Insulin-Dependent Diabetes Mellitus
‡9
1
|
|
919
|
|
|
‡a
pathologicalevolutionofglucoseresponsecurvesduringtheprogressiontotype1diabetesinthetrialnetpathwaytopreventionstudy
‡A
The Pathological Evolution of Glucose Response Curves During the Progression to Type 1 Diabetes in the TrialNet Pathway to Prevention Study
‡9
1
|
|
919
|
|
|
‡a
celiacautoimmunityisassociatedwithlowerbloodpressureandrenalriskintype1diabetes
‡A
Celiac Autoimmunity Is Associated With Lower Blood Pressure and Renal Risk in Type 1 Diabetes
‡9
1
|
|
919
|
|
|
‡a
naturalhistoryofdiabetescomplicationsthepittsburghstudies
‡A
The natural history of diabetes complications: the Pittsburgh studies
‡9
1
|
|
919
|
|
|
‡a
investigationofageatonsetasariskfactorformortalityinpersonswithinsulindependentdiabetesmellitususingcoxproportionalhazardsmodels
‡A
The investigation of age at onset as a risk factor for mortality in persons with insulin-dependent diabetes mellitus using Cox proportional hazards models
‡9
1
|
|
919
|
|
|
‡a
interfacebetweenepidemiologyandmolecularbiologyinthesearchforthecausesofinsulindependentdiabetesmellitus
‡A
The interface between epidemiology and molecular biology in the search for the causes of insulin-dependent diabetes mellitus
‡9
1
|
|
919
|
|
|
‡a
impactoftheapolipoproteinepolymorphismonthelipoproteinprofileininsulindependentdiabetesthepittsburghepidemiologyofdiabetescomplicationsstudy9
‡A
The impact of the apolipoprotein E polymorphism on the lipoprotein profile in insulin-dependent diabetes: the Pittsburgh Epidemiology of Diabetes Complications Study IX.
‡9
1
|
|
919
|
|
|
‡a
epidemiologyofdiabetescomplicationsstudy4correlatesofdiabeticbackgroundandproliferativeretinopathy
‡A
The epidemiology of diabetes complications study. IV. Correlates of diabetic background and proliferative retinopathy
‡9
1
|
|
919
|
|
|
‡a
epidemiologyandetiologyofinsulindependentdiabetesmellitusinthechild
‡A
[The epidemiology and etiology of insulin dependent diabetes mellitus in the child]
‡9
1
|
|
919
|
|
|
‡a
effectsofwaterdeprivationandwaterloadingduringtreatmentwith1deamino8500argininevasopressinincentraldiabetesinsipidusinchildhood
‡A
The effects of water deprivation and water loading during treatment with 1-deamino-8-D-arginine vasopressin in central diabetes insipidus in childhood
‡9
1
|
|
919
|
|
|
‡a
effectofcyproheptadineandhumangrowthhormoneonadrenocorticalfunctioninchildrenwithhypopituitarism
‡A
The effect of cyproheptadine and human growth hormone on adrenocortical function in children with hypopituitarism
‡9
1
|
|
919
|
|
|
‡a
effectofageoninsulinsensitivityandinsulinsecretionin1degreerelativesoftype1diabeticpatientsapopulationanalysis
‡A
The effect of age on insulin sensitivity and insulin secretion in first-degree relatives of type 1 diabetic patients: a population analysis
‡9
1
|
|
919
|
|
|
‡a
developmentoftype1insulindependentdiabetesmellitus2contrastingpresentations
‡A
The development of Type 1 (insulin-dependent) diabetes mellitus: two contrasting presentations
‡9
1
|
|
919
|
|
|
‡a
developmentoftype1
‡A
The development of Type 1
‡9
1
|
|
919
|
|
|
‡a
dawnphenomenoncomparisonbetweennormalandinsulindependentdiabeticadolescents
‡A
The Dawn Phenomenon: Comparison between Normal and Insulin-Dependent Diabetic Adolescents
‡9
1
|
|
919
|
|
|
‡a
changingcourseofdiabeticnephropathylowdensitylipoproteincholesterolandbloodpressurecorrelatewithregressionofproteinuria
‡A
The changing course of diabetic nephropathy: low-density lipoprotein cholesterol and blood pressure correlate with regression of proteinuria.
‡9
1
|
|
919
|
|
|
‡a
cardiovascularriskprofileofadolescentswithinsulindependentdiabetesmellitus
‡A
The cardiovascular risk profile of adolescents with insulin-dependent diabetes mellitus
‡9
1
|
|
919
|
|
|
‡a
associationofwaisthipratiowithdiabetescomplicationsinanadultiddmpopulation
‡A
The association of waist/hip ratio with diabetes complications in an adult IDDM population
‡9
1
|
|
919
|
|
|
‡a
associationbetweenafamilyhistoryoftype2diabetesandcoronaryarterydiseaseinatype1diabetespopulation
‡A
The association between a family history of type 2 diabetes and coronary artery disease in a type 1 diabetes population
‡9
1
|
|
919
|
|
|
‡a
30yearnaturalhistoryoftype1diabetescomplicationsthepittsburghepidemiologyofdiabetescomplicationsstudyexperience
‡A
The 30-year natural history of type 1 diabetes complications: the Pittsburgh Epidemiology of Diabetes Complications Study experience
‡9
1
|
|
919
|
|
|
‡a
targetingofpancreaticgliaintype1diabetes
‡A
Targeting of pancreatic glia in type 1 diabetes.
‡9
1
|
|
919
|
|
|
‡a
tcellsofmultiplesclerosispatientstargetacommonenvironmentalpeptidethatcausesencephalitisinmice
‡A
T cells of multiple sclerosis patients target a common environmental peptide that causes encephalitis in mice
‡9
1
|
|
919
|
|
|
‡a
subclinicalatherosclerosisandestimatedglucosedisposalrateaspredictorsofmortalityintype1diabetes
‡A
Subclinical atherosclerosis and estimated glucose disposal rate as predictors of mortality in type 1 diabetes
‡9
1
|
|
919
|
|
|
‡a
spontaneouswholebloodplateletaggregationhematologicalvariablesandcomplicationsininsulindependentdiabetesmellitusthepittsburghepidemiologyofdiabetescomplicationsstudy
‡A
Spontaneous whole blood platelet aggregation, hematological variables and complications in insulin-dependent diabetes mellitus: the Pittsburgh Epidemiology of Diabetes Complications Study
‡9
1
|
|
919
|
|
|
‡a
sodiumlithiumcountertransportactivityisdecreasedafterweightlossinhealthyobesemen
‡A
Sodium-lithium countertransport activity is decreased after weight loss in healthy obese men.
‡9
1
|
|
919
|
|
|
‡a
singleisletautoantibodyatdiagnosisofclinicaltype1diabetesisassociatedwitholderageandinsulinresistance
‡A
Single Islet Autoantibody at Diagnosis of Clinical Type 1 Diabetes is Associated With Older Age and Insulin Resistance
‡9
1
|
|
919
|
|
|
‡a
sexualdimorphismininsulinsensitivityinadolescentswithinsulindependentdiabetesmellitus
‡A
Sexual dimorphism in insulin sensitivity in adolescents with insulin-dependent diabetes mellitus.
‡9
1
|
|
919
|
|
|
‡a
sexdifferencesinthecoronaryheartdiseaseriskprofileapossibleroleforinsulinthebeavercountystudy
‡A
Sex differences in the coronary heart disease risk profile: a possible role for insulin. The Beaver County Study
‡9
1
|
|
919
|
|
|
‡a
sexdifferencesinsecondaryattackrateofiddmtosiblingsofprobandsthrougholderagespittsburghetiologyofiddmstudy
‡A
Sex differences in secondary attack rate of IDDM to siblings of probands through older ages. Pittsburgh Etiology of IDDM Study
‡9
1
|
|
919
|
|
|
‡a
sexdifferencesindiabetes
‡A
Sex differences in diabetes
‡9
1
|
|
919
|
|
|
‡a
screeningstagingandnamingofpresymptomatictype1diabetes
‡A
Screening, staging, and naming of presymptomatic type 1 diabetes.
‡9
1
|
|
919
|
|
|
‡a
rituximabblymphocytedepletionandpreservationofbetacellfunction
‡A
Rituximab, B-Lymphocyte Depletion, and Preservation of Beta-Cell Function
‡9
1
|
|
919
|
|
|
‡a
residualbetacellfunctioninchildrenwithiddmreproducibilityoftestingandfactorsinfluencinginsulinsecretoryreserve
‡A
Residual beta-cell function in children with IDDM: reproducibility of testing and factors influencing insulin secretory reserve
‡9
1
|
|
919
|
|
|
‡a
relationshipsandhealthamongemergingadultswithandwithouttype1diabetes
‡A
Relationships and health among emerging adults with and without Type 1 diabetes.
‡9
1
|
|
919
|
|
|
‡a
relationshipofadiponectinandleptinwithautoimmunityinchildrenwithnewonsettype1diabetesapilotstudy
‡A
Relationship of adiponectin and leptin with autoimmunity in children with new-onset type 1 diabetes: a pilot study
‡9
1
|
|
919
|
|
|
‡a
relationsofbehavioralautonomytohealthoutcomesamongemergingadultswithandwithouttype1diabetes
‡A
Relations of behavioral autonomy to health outcomes among emerging adults with and without type 1 diabetes
‡9
1
|
|
919
|
|
|
‡a
relationofstressfullifeeventstometaboliccontrolamongadolescentswithdiabetes5yearlongitudinalstudy
‡A
Relation of stressful life events to metabolic control among adolescents with diabetes: 5-year longitudinal study
‡9
1
|
|
919
|
|
|
‡a
relationofparentknowledgetoglycemiccontrolamongemergingadultswithtype1diabetesamediationalmodel
‡A
Relation of parent knowledge to glycemic control among emerging adults with type 1 diabetes: a mediational model
‡9
1
|
|
919
|
|
|
‡a
regionaldifferencesinmilkandcomplementaryfeedingpatternsininfantsparticipatinginaninternationalnutritionaltype1diabetespreventiontrial
‡A
Regional differences in milk and complementary feeding patterns in infants participating in an international nutritional type 1 diabetes prevention trial
‡9
1
|
|
919
|
|
|
‡a
regionalcerebralbloodflowduringhypoglycaemiainchildrenwithiddm
‡A
Regional cerebral blood flow during hypoglycaemia in children with IDDM
‡9
1
|
|
919
|
|
|
‡a
randomizedefficacytrialofearlypreconceptioncounselingfordiabeticteensreadygirls
‡A
Randomized efficacy trial of early preconception counseling for diabetic teens (READY-girls).
‡9
1
|
|
919
|
|
|
‡a
psychosocialpredictorsofdiabetesriskfactorsandcomplicationsan11yearfollowup
‡A
Psychosocial predictors of diabetes risk factors and complications: An 11-year follow-up
‡9
1
|
|
919
|
|
|
‡a
psychosocialcorrelatesofglycemiccontrolthepittsburghepidemiologyofdiabetescomplicationsedcstudy
‡A
Psychosocial correlates of glycemic control: the Pittsburgh Epidemiology of Diabetes Complications (EDC) Study
‡9
1
|
|
919
|
|
|
‡a
psychosocialcorrelatesofglycemiccontrolthepittsburghepidemiologyofdiabetescomplications
‡A
Psychosocial correlates of glycemic control: the Pittsburgh Epidemiology of Diabetes Complications
‡9
1
|
|
919
|
|
|
‡a
proteinuriainchildrenwithinsulindependentdiabetesrelationshiptodurationofdiseasemetaboliccontrolandretinalchanges
‡A
Proteinuria in children with insulin-dependent diabetes: relationship to duration of disease, metabolic control, and retinal changes
‡9
1
|
|
919
|
|
|
‡a
progressiveretinopathywithimprovedcontrolindiabeticdwarfismmauriacssyndrome
‡A
Progressive retinopathy with improved control in diabetic dwarfism (Mauriac's syndrome)
‡9
1
|
|
919
|
|
|
‡a
progressiveretinopathywithimprovedcontrolindiabeticdwarfism
‡A
Progressive retinopathy with improved control in diabetic dwarfism
‡9
1
|
|
919
|
|
|
‡a
progressiveerosionofβcellfunctionprecedestheonsetofhyperglycemiainthenodmousemodeloftype1diabetes
‡A
Progressive erosion of β-cell function precedes the onset of hyperglycemia in the NOD mouse model of type 1 diabetes
‡9
1
|
|
919
|
|
|
‡a
progressiontoinsulinrequiringdiabetesinseronegativeprediabeticsubjectstheroleof2hladqhighriskhaplotypes
‡A
Progression to insulin-requiring diabetes in seronegative prediabetic subjects: the role of two HLA-DQ high-risk haplotypes
‡9
1
|
|
919
|
|
|
‡a
prevalenceofcomplicationsiniddmbysexanddurationpittsburghepidemiologyofdiabetescomplicationsstudy2
‡A
Prevalence of complications in IDDM by sex and duration. Pittsburgh Epidemiology of Diabetes Complications Study II
‡9
1
|
|
919
|
|
|
‡a
prevalenceandincidenceofclinicallyrecognizedcasesoftype1diabetesinchildrenandadolescentsinrwandaafrica
‡A
Prevalence and incidence of clinically recognized cases of Type 1 diabetes in children and adolescents in Rwanda, Africa.
‡9
1
|
|
919
|
|
|
‡a
predictorsofmicroalbuminuriainindividualswithiddmpittsburghepidemiologyofdiabetescomplicationsstudy
‡A
Predictors of microalbuminuria in individuals with IDDM. Pittsburgh Epidemiology of Diabetes Complications Study
‡9
1
|
|
919
|
|
|
‡a
predictorsofmetaboliccontrolamongadolescentswithdiabetesa4yearlongitudinalstudy
‡A
Predictors of metabolic control among adolescents with diabetes: a 4-year longitudinal study
‡9
1
|
|
919
|
|
|
‡a
coexistenceoftype1andtype2diabetesmellitusdoublediabetes
‡A
Coexistence of type 1 and type 2 diabetes mellitus: "double" diabetes?
‡9
1
|
|
919
|
|
|
‡a
changesinglycaemiccontrolandriskofcoronaryarterydiseaseintype1diabetesmellitusfindingsfromthepittsburghepidemiologyofdiabetescomplicationsstudyedc
‡A
Changes in glycaemic control and risk of coronary artery disease in type 1 diabetes mellitus: findings from the Pittsburgh Epidemiology of Diabetes Complications Study (EDC).
‡9
1
|
|
919
|
|
|
‡a
costimulationmodulationwithabataceptinpatientswithrecentonsettype1diabetesarandomiseddoubleblindplacebocontrolledtrial
‡A
Co-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled trial
‡9
1
|
|
919
|
|
|
‡a
poissonregressionmodelingoftemporalvariationinincidenceofchildhoodinsulindependentdiabetesmellitusinalleghenycountypennsylvaniaandwielkopolskapoland1970
‡A
Poisson regression modeling of temporal variation in incidence of childhood insulin-dependent diabetes mellitus in Allegheny County, Pennsylvania, and Wielkopolska, Poland, 1970-1985.
‡9
1
|
|
919
|
|
|
‡a
plasmainsulinandlipoproteinconcentrationsanatherogenicassociation
‡A
Plasma insulin and lipoprotein concentrations: an atherogenic association?
‡9
1
|
|
919
|
|
|
‡a
plasmacatecholamineresponsestohypoglycemiainchildrenandadolescentswithiddm
‡A
Plasma catecholamine responses to hypoglycemia in children and adolescents with IDDM
‡9
1
|
|
919
|
|
|
‡a
pittsburghinsulindependentdiabetesmellitusmorbidityandmortalitystudyphysicalactivityanddiabeticcomplications
‡A
Pittsburgh Insulin-Dependent Diabetes Mellitus Morbidity and Mortality Study: physical activity and diabetic complications
‡9
1
|
|
919
|
|
|
‡a
pittsburghepidemiologyofdiabetescomplicationsstudymeasuringdiabeticneuropathyfollowupstudyresults
‡A
Pittsburgh Epidemiology of Diabetes Complications Study. Measuring diabetic neuropathy follow-up study results
‡9
1
|
|
919
|
|
|
‡a
physiciansselfperceptionsofcareforemergingadultswithtype1diabetes
‡A
PHYSICIANS' SELF-PERCEPTIONS OF CARE FOR EMERGING ADULTS WITH TYPE 1 DIABETES.
‡9
1
|
|
919
|
|
|
‡a
physicalactivityinsulinsensitivityandthelipoproteinprofileinyoungadultsthebeavercountystudy
‡A
Physical activity, insulin sensitivity, and the lipoprotein profile in young adults: the Beaver County Study
‡9
1
|
|
919
|
|
|
‡a
phosphatereplacementduringtreatmentofdiabeticketosiseffectsoncalciumandphosphorushomeostasis
‡A
Phosphate replacement during treatment of diabetic ketosis. Effects on calcium and phosphorus homeostasis
‡9
1
|
|
919
|
|
|
‡a
persistenttcellanergyinhumantype1diabetes
‡A
Persistent T cell anergy in human type 1 diabetes.
‡9
1
|
|
919
|
|
|
‡a
persistent100peptidelevelsandmicrovascularcomplicationsinchildhoodonsettype1diabetesoflongduration
‡A
Persistent C-peptide levels and microvascular complications in childhood onset type 1 diabetes of long duration
‡9
1
|
|
919
|
|
|
‡a
peptidedosemhcaffinityandtargetselfantigenexpressionarecriticalforeffectiveimmunotherapyofnonobesediabeticmouseprediabetes
‡A
Peptide dose, MHC affinity, and target self-antigen expression are critical for effective immunotherapy of nonobese diabetic mouse prediabetes
‡9
1
|
|
919
|
|
|
‡a
parentandadolescentdistributionofresponsibilityfordiabetesselfcarelinkstohealthoutcomes
‡A
Parent and adolescent distribution of responsibility for diabetes self-care: links to health outcomes
‡9
1
|
|
919
|
|
|
‡a
operationalizingandexaminingfamilyplanningvigilanceinadultwomenwithtype1diabetes
‡A
Operationalizing and Examining Family Planning Vigilance in Adult Women With Type 1 Diabetes
‡9
1
|
|
919
|
|
|
‡a
olderageofchildhoodtype1diabetesonsetisassociatedwithisletautoantibodypositivity30yearslaterthepittsburghepidemiologyofdiabetescomplicationsstudy
‡A
Older age of childhood type 1 diabetes onset is associated with islet autoantibody positivity >30 years later: the Pittsburgh Epidemiology of Diabetes Complications Study
‡9
1
|
|
919
|
|
|
‡a
obesityisletcellautoimmunityandcardiovascularriskfactorsinyouthatonsetoftype1autoimmunediabetes
‡A
Obesity, islet cell autoimmunity, and cardiovascular risk factors in youth at onset of type 1 autoimmune diabetes
‡9
1
|
|
919
|
|
|
‡a
neuronaltcellautoreactivityisamplifiedinoverweightchildrenwithnewonsetinsulinrequiringdiabetes
‡A
Neuronal T-cell autoreactivity is amplified in overweight children with new-onset insulin-requiring diabetes.
‡9
1
|
|
919
|
|
|
‡a
needforgeneticeducationfortype1diabetes
‡A
Need for genetic education for type 1 diabetes
‡9
1
|
|
919
|
|
|
‡a
multivariateanalysesoftheriskofinsulindependentdiabetesmellitusforsiblingsofinsulindependentdiabeticpatients
‡A
Multivariate analyses of the risk of insulin-dependent diabetes mellitus for siblings of insulin-dependent diabetic patients
‡9
1
|
|
919
|
|
|
‡a
motorvehicleaccidentsandiddm
‡A
Motor vehicle accidents and IDDM
‡9
1
|
|
919
|
|
|
‡a
motherdaughterdyadicapproachforstartingpreconceptioncounselingatpubertyingirlswithdiabetes
‡A
Mother-daughter dyadic approach for starting preconception counseling at puberty in girls with diabetes
‡9
1
|
|
919
|
|
|
‡a
measuringsubclinicalneuropathydoesitrelatetoclinicalneuropathypittsburghepidemiologyofdiabetescomplicationsstudy5
‡A
Measuring subclinical neuropathy: does it relate to clinical neuropathy? Pittsburgh epidemiology of diabetes complications study-V
‡9
1
|
|
919
|
|
|
‡a
measuringdiabeticneuropathyassessmentandcomparisonofclinicalexaminationandquantitativesensorytesting
‡A
Measuring diabetic neuropathy. Assessment and comparison of clinical examination and quantitative sensory testing
‡9
1
|
|
919
|
|
|
‡a
changingimpactofmodifiableriskfactorsontheincidenceofmajoroutcomesoftype1diabetesthepittsburghepidemiologyofdiabetescomplicationsstudy
‡A
Changing impact of modifiable risk factors on the incidence of major outcomes of type 1 diabetes: the Pittsburgh Epidemiology of Diabetes Complications Study
‡9
1
|
|
919
|
|
|
‡a
lowdoseantithymocyteglobulinpreserves100peptidereduceshba1candincreasesregulatorytoconventionaltcellratiosinnewonsettype1diabetes2yearclinicaltrialdata
‡A
Low-Dose Anti-Thymocyte Globulin Preserves C-Peptide, Reduces HbA1c, and Increases Regulatory to Conventional T-Cell Ratios in New-Onset Type 1 Diabetes: Two-Year Clinical Trial Data
‡9
1
|
|
919
|
|
|
‡a
lowdoseantithymocyteglobulinatgpreservesβcellfunctionandimproveshbainnewonsettype1diabetes
‡A
Low-Dose Anti-Thymocyte Globulin (ATG) Preserves β-Cell Function and Improves HbA in New-Onset Type 1 Diabetes
‡9
1
|
|
919
|
|
|
‡a
lowdoseantithymocyteglobulin
‡A
Low-Dose Anti-Thymocyte Globulin
‡9
1
|
|
919
|
|
|
‡a
longtermeffectsoftheboosterenhancedreadygirlspreconceptioncounselingprogramonintentionsandbehaviorsforfamilyplanninginteenswithdiabetes
‡A
Long-term effects of the booster-enhanced READY-Girls preconception counseling program on intentions and behaviors for family planning in teens with diabetes
‡9
1
|
|
919
|
|
|
‡a
lipoproteinaconcentrationshowslittlerelationshiptoiddmcomplicationsinthepittsburghepidemiologyofdiabetescomplicationsstudycohort
‡A
Lipoprotein(a) concentration shows little relationship to IDDM complications in the Pittsburgh Epidemiology of Diabetes Complications Study cohort
‡9
1
|
|
919
|
|
|
‡a
lipidandbloodpressuretreatmentgoalsfortype1diabetes10yearincidencedatafromthepittsburghepidemiologyofdiabetescomplicationsstudy
‡A
Lipid and blood pressure treatment goals for type 1 diabetes: 10-year incidence data from the Pittsburgh Epidemiology of Diabetes Complications Study
‡9
1
|
|
919
|
|
|
‡a
leptinbeforeandafterinsulintherapyinchildrenwithnewonsettype1diabetes
‡A
Leptin before and after insulin therapy in children with new-onset type 1 diabetes
‡9
1
|
|
919
|
|
|
‡a
largescaleprospectivetcellfunctionassaysinshippedunfrozenbloodsamplesexperiencesfromthemulticentertrigrtrial
‡A
Large-scale prospective T cell function assays in shipped, unfrozen blood samples: experiences from the multicenter TRIGR trial
‡9
1
|
|
919
|
|
|
‡a
knowledgeattitudesandbehaviorsrelatedtosexualityandfamilyplanninginadolescentwomenwithandwithoutdiabetes
‡A
Knowledge, attitudes and behaviors related to sexuality and family planning in adolescent women with and without diabetes
‡9
1
|
|
919
|
|
|
‡a
ispadclinicalpracticeconsensusguidelines2018managementofcysticfibrosisrelateddiabetesinchildrenandadolescents
‡A
ISPAD Clinical Practice Consensus Guidelines 2018: Management of cystic fibrosis-related diabetes in children and adolescents
‡9
1
|
|
919
|
|
|
‡a
ispadclinicalpracticeconsensusguidelines2014managementofcysticfibrosisrelateddiabetesinchildrenandadolescents
‡A
ISPAD Clinical Practice Consensus Guidelines 2014. Management of cystic fibrosis-related diabetes in children and adolescents
‡9
1
|
|
919
|
|
|
‡a
introducingtheendotypeconcepttoaddressthechallengeofdiseaseheterogeneityintype1diabetes
‡A
Introducing the Endotype Concept to Address the Challenge of Disease Heterogeneity in Type 1 Diabetes
‡9
1
|
|
919
|
|
|
‡a
interleukin1antagonismintype1diabetesofrecentonset2multicentrerandomiseddoubleblindplacebocontrolledtrials
‡A
Interleukin-1 antagonism in type 1 diabetes of recent onset: two multicentre, randomised, double-blind, placebo-controlled trials
‡9
1
|
|
919
|
|
|
‡a
intensivediabetestherapyinchildhoodisitachievableisitdesirableisitsafe
‡A
Intensive diabetes therapy in childhood: is it achievable? Is it desirable? Is it safe?
‡9
1
|
|
919
|
|
|
‡a
insulinresistancerelatedfactorsbutnotglycemiapredictcoronaryarterydiseaseintype1diabetes10yearfollowupdatafromthepittsburghepidemiologyofdiabetescomplicationsstudy
‡A
Insulin resistance-related factors, but not glycemia, predict coronary artery disease in type 1 diabetes: 10-year follow-up data from the Pittsburgh Epidemiology of Diabetes Complications Study
‡9
1
|
|
919
|
|
|
‡a
insulindependentdiabetesmellitusphysicalactivityanddeath
‡A
Insulin-dependent diabetes mellitus, physical activity, and death
‡9
1
|
|
919
|
|
|
‡a
insulindependentdiabetesmellitusmortalitytheriskofcigarettesmoking
‡A
Insulin-dependent diabetes mellitus mortality. The risk of cigarette smoking
‡9
1
|
|
919
|
|
|
‡a
insulinasapredictorofcoronaryheartdiseaseinteractionwithapolipoproteinephenotypeareportfromthemultipleriskfactorinterventiontrial
‡A
Insulin as a predictor of coronary heart disease: interaction with apolipoprotein E phenotype. A report from the Multiple Risk Factor Intervention Trial
‡9
1
|
|
919
|
|
|
‡a
infantfeedingandtimingofcomplementaryfoodsinthedevelopmentoftype1diabetes
‡A
Infant Feeding and Timing of Complementary Foods in the Development of Type 1 Diabetes.
‡9
1
|
|
919
|
|
|
‡a
infantfeedingandautoimmunediabetes
‡A
Infant feeding and autoimmune diabetes.
‡9
1
|
|
919
|
|
|
‡a
increasedexpressionofmonocytecd11bmac1inoverweightrecentonsettype1diabeticchildren
‡A
Increased Expression of Monocyte CD11b (Mac-1) in Overweight Recent-Onset Type 1 Diabetic Children
‡9
1
|
|
919
|
|
|
‡a
incidenceofesrdandsurvivalafterrenalreplacementtherapyinpatientswithtype1diabetesareportfromthealleghenycountyregistry
‡A
Incidence of ESRD and survival after renal replacement therapy in patients with type 1 diabetes: a report from the Allegheny County Registry
‡9
1
|
|
919
|
|
|
‡a
impairedcounterregulatoryhormoneresponsestohypoglycemiainchildrenandadolescentswithnewonsetiddm
‡A
Impaired counterregulatory hormone responses to hypoglycemia in children and adolescents with new onset IDDM
‡9
1
|
|
919
|
|
|
‡a
impactofageandantibodytypeonprogressionfromsingletomultipleautoantibodiesintype1diabetesrelatives
‡A
Impact of Age and Antibody Type on Progression From Single to Multiple Autoantibodies in Type 1 Diabetes Relatives
‡9
1
|
|
919
|
|
|
‡a
impactofapreconceptioncounselingprogramforteenswithtype1diabetesreadygirlsonpatientproviderinteractionresourceutilizationandcost
‡A
Impact of a preconception counseling program for teens with type 1 diabetes (READY-Girls) on patient-provider interaction, resource utilization, and cost
‡9
1
|
|
919
|
|
|
‡a
hypoplasiaofthepancreasinapatientwithtype1diabetesmellitus
‡A
Hypoplasia of the pancreas in a patient with type I diabetes mellitus
‡9
1
|
|
919
|
|
|
‡a
hypoglycemiaacomplicationofdiabetestherapyinchildren
‡A
Hypoglycemia: a complication of diabetes therapy in children
‡9
1
|
|
919
|
|
|
‡a
hypertensionasariskfactorfordiabeticneuropathyaprospectivestudy
‡A
Hypertension as a risk factor for diabetic neuropathy: a prospective study
‡9
1
|
|
919
|
|
|
‡a
hydrolyzedinfantformulaandearlyβcellautoimmunityarandomizedclinicaltrial
‡A
Hydrolyzed infant formula and early β-cell autoimmunity: a randomized clinical trial
‡9
1
|
|
919
|
|
|
‡a
humoralautoimmunityagainsttheextracellulardomainoftheneuroendocrineautoantigenia2heightenstheriskoftype1diabetes
‡A
Humoral autoimmunity against the extracellular domain of the neuroendocrine autoantigen IA-2 heightens the risk of type 1 diabetes
‡9
1
|
|
919
|
|
|
‡a
humaninsulinuseandhypoglycaemiainsightsfromthepittsburghepidemiologyofdiabetescomplicationsstudy
‡A
Human insulin use and hypoglycaemia: insights from the Pittsburgh Epidemiology of Diabetes Complications Study
‡9
1
|
|
919
|
|
|
‡a
hormonalmetabolicandneuroradiologicabnormalitiesassociatedwithseptoopticdysplasia
‡A
Hormonal, metabolic, and neuroradiologic abnormalities associated with septo-optic dysplasia
‡9
1
|
|
919
|
|
|
‡a
hlaheterogeneityofinsulindependentdiabetesmellitusatdiagnosisthepittsburghiddmstudy
‡A
HLA heterogeneity of insulin-dependent diabetes mellitus at diagnosis. The Pittsburgh IDDM study
‡9
1
|
|
919
|
|
|
‡a
hladrb11501dqa10102dqb10602haplotypeprotectsautoantibodypositiverelativesfromtype1diabetesthroughoutthestagesofdiseaseprogression
‡A
HLA-DRB1*15:01-DQA1*01:02-DQB1*06:02 Haplotype Protects Autoantibody-Positive Relatives From Type 1 Diabetes Throughout the Stages of Disease Progression
‡9
1
|
|
919
|
|
|
‡a
heightatdiagnosisofinsulindependentdiabetesinpatientsandtheirnondiabeticfamilymembers
‡A
Height at diagnosis of insulin dependent diabetes in patients and their non-diabetic family members
‡9
1
|
|
919
|
|
|
‡a
healthlifeandautomobileinsurancecharacteristicsinadultswithiddm
‡A
Health, life, and automobile insurance characteristics in adults with IDDM.
‡9
1
|
|
919
|
|
|
‡a
healthinsuranceandthefinancialimpactofiddminfamilieswithachildwithiddm
‡A
Health insurance and the financial impact of IDDM in families with a child with IDDM.
‡9
1
|
|
919
|
|
|
‡a
growthhormonetherapyforpatientswithturnerssyndrome
‡A
Growth hormone therapy for patients with Turner's syndrome
‡9
1
|
|
919
|
|
|
‡a
growthhormonetherapyandtumorrecurrencefindingsinchildrenwithbrainneoplasmsandhypopituitarism
‡A
Growth hormone therapy and tumor recurrence. Findings in children with brain neoplasms and hypopituitarism
‡9
1
|
|
919
|
|
|
‡a
growthdifferencesbetweennorthamericanandeuropeanchildrenatriskfortype1diabetes
‡A
Growth differences between North American and European children at risk for type 1 diabetes
‡9
1
|
|
919
|
|
|
‡a
glycosylatedhemoglobinascreeningtestfordiabetesmellitus
‡A
Glycosylated hemoglobin: a screening test for diabetes mellitus?
‡9
1
|
|
919
|
|
|
‡a
glycosylatedhaemoglobininchildrenwithinsulindependentdiabetesmellitus
‡A
Glycosylated haemoglobin in children with insulin-dependent diabetes mellitus
‡9
1
|
|
919
|
|
|
‡a
glycemiaorinwomenestimatedglucosedisposalratepredictlowerextremityarterialdiseaseeventsintype1diabetes
‡A
Glycemia (or, in women, estimated glucose disposal rate) predict lower extremity arterial disease events in type 1 diabetes
‡9
1
|
|
919
|
|
|
‡a
glucosetoleranceinsiblingsoftype1diabeticpatientsrelationshiptohlastatus
‡A
Glucose tolerance in siblings of type 1 diabetic patients: relationship to HLA status
‡9
1
|
|
919
|
|
|
‡a
changingprevalenceofoverweightchildrenandadolescentsatonsetofinsulintreateddiabetes
‡A
Changing Prevalence of Overweight Children and Adolescents at Onset of Insulin-Treated Diabetes
‡9
1
|
|
919
|
|
|
‡a
characteristicsofslowprogressiontodiabetesinmultipleisletautoantibodypositiveindividualsfrom5longitudinalcohortsthesnailstudy
‡A
Characteristics of slow progression to diabetes in multiple islet autoantibody-positive individuals from five longitudinal cohorts: the SNAIL study.
‡9
1
|
|
919
|
|
|
‡a
glucosecontrolinrwandanyouthwithtype1diabetesfollowingestablishmentofsystematichba1cbasedcareandeducation
‡A
Glucose control in Rwandan youth with type 1 diabetes following establishment of systematic, HbA1c based, care and education
‡9
1
|
|
919
|
|
|
‡a
glucagonresponsestohypoglycemiainchildrenandadolescentswithiddm
‡A
Glucagon responses to hypoglycemia in children and adolescents with IDDM
‡9
1
|
|
919
|
|
|
‡a
futureinterventiontrialsintype1diabetes
‡A
Future intervention trials in type 1 diabetes
‡9
1
|
|
919
|
|
|
‡a
friendshipandromanticrelationshipsamongemergingadultswithandwithouttype1diabetes
‡A
Friendship and romantic relationships among emerging adults with and without type 1 diabetes
‡9
1
|
|
919
|
|
|
‡a
featuredarticletrajectoriesofglycemiccontroloveradolescenceandemergingadulthoodan11yearlongitudinalstudyofyouthwithtype1diabetes
‡A
Featured Article: Trajectories of Glycemic Control Over Adolescence and Emerging Adulthood: An 11-Year Longitudinal Study of Youth With Type 1 Diabetes
‡9
1
|
|
919
|
|
|
‡a
familieswithchildrenwithdiabetesimplicationsofparentstressforparentandchildhealth
‡A
Families with children with diabetes: implications of parent stress for parent and child health
‡9
1
|
|
919
|
|
|
‡a
familialinsulindependentdiabetesmellitusandhemipancreatectomy
‡A
Familial insulin-dependent diabetes mellitus and hemipancreatectomy
‡9
1
|
|
919
|
|
|
‡a
familialandsporadicinsulindependentdiabetesevidenceforheterogeneousetiologies
‡A
Familial and sporadic insulin-dependent diabetes: evidence for heterogeneous etiologies?
‡9
1
|
|
919
|
|
|
‡a
factorsassociatedwithavoidanceofseverecomplicationsafter25yrofiddmpittsburghepidemiologyofdiabetescomplicationsstudy1
‡A
Factors associated with avoidance of severe complications after 25 yr of IDDM. Pittsburgh Epidemiology of Diabetes Complications Study I.
‡9
1
|
|
919
|
|
|
‡a
factorsaffectingglycosylatedhemoglobinvaluesinchildrenwithinsulindependentdiabetes
‡A
Factors affecting glycosylated hemoglobin values in children with insulin-dependent diabetes
‡9
1
|
|
919
|
|
|
‡a
excessbmiinchildhoodamodifiableriskfactorfortype1diabetesdevelopment
‡A
Excess BMI in Childhood: A Modifiable Risk Factor for Type 1 Diabetes Development?
‡9
1
|
|
919
|
|
|
‡a
excessbmiacceleratesisletautoimmunityinolderchildrenandadolescents
‡A
Excess BMI Accelerates Islet Autoimmunity in Older Children and Adolescents
‡9
1
|
|
919
|
|
|
‡a
evolutionofthepittsburghstudiesoftheepidemiologyofinsulindependentdiabetesmellituspittsburghdiabetesepidemiologyandetiologyresearchgroup
‡A
Evolution of the Pittsburgh studies of the epidemiology of insulin-dependent diabetes mellitus. Pittsburgh Diabetes Epidemiology and Etiology Research Group
‡9
1
|
|
919
|
|
|
‡a
evidenceforheterogeneouspathogenesisofinsulintreateddiabetesinblackandwhitechildren
‡A
Evidence for heterogeneous pathogenesis of insulin-treated diabetes in black and white children
‡9
1
|
|
919
|
|
|
‡a
epidemiologypathophysiologyandprognosticimplicationsofcysticfibrosisrelateddiabetesatechnicalreview
‡A
Epidemiology, pathophysiology, and prognostic implications of cystic fibrosis-related diabetes: a technical review
‡9
1
|
|
919
|
|
|
‡a
epidemiologicalcorrelatesofdiabeticneuropathyreportfrompittsburghepidemiologyofdiabetescomplicationsstudy
‡A
Epidemiological correlates of diabetic neuropathy. Report from Pittsburgh Epidemiology of Diabetes Complications Study
‡9
1
|
|
919
|
|
|
‡a
employmentspectrumofiddm
‡A
Employment spectrum of IDDM
‡9
1
|
|
919
|
|
|
‡a
employmentpatternsamongparentsofchildrenwithinsulindependentdiabetesmellitusiddm
‡A
Employment patterns among parents of children with insulin-dependent diabetes mellitus (IDDM)
‡9
1
|
|
919
|
|
|
‡a
emergingadultswithtype1diabetesacomparisontopeerswithoutdiabetes
‡A
Emerging adults with type 1 diabetes: a comparison to peers without diabetes
‡9
1
|
|
919
|
|
|
‡a
electroencephalographicchangesindiabeticketosisinchildrenwithnewlyandpreviouslydiagnosedinsulindependentdiabetesmellitus
‡A
Electroencephalographic changes in diabetic ketosis in children with newly and previously diagnosed insulin-dependent diabetes mellitus
‡9
1
|
|
919
|
|
|
‡a
effectsofimprovedglycemiccontrolonmicroalbuminuriainadolescentswithinsulindependentdiabetesmellitus
‡A
Effects of improved glycemic control on microalbuminuria in adolescents with insulin-dependent diabetes mellitus
‡9
1
|
|
919
|
|
|
‡a
effectsofenhancedconventionaltherapyonmetaboliccontrolinchildrenwithinsulindependentdiabetesmellitus
‡A
Effects of enhanced conventional therapy on metabolic control in children with insulin-dependent diabetes mellitus
‡9
1
|
|
919
|
|
|
‡a
effectofhydrolyzedinfantformulavsconventionalformulaonriskoftype1diabetesthetrigrrandomizedclinicaltrial
‡A
Effect of Hydrolyzed Infant Formula vs Conventional Formula on Risk of Type 1 Diabetes: The TRIGR Randomized Clinical Trial
‡9
1
|
|
919
|
|
|
‡a
editorialtributemarkasperling1500editorinchiefpediatricdiabetes2000
‡A
Editorial Tribute: Mark A. Sperling, MD, Editor-in-Chief, Pediatric Diabetes 2000-2017
‡9
1
|
|
919
|
|
|
‡a
1deamino8500argininevasopressininthetreatmentofcentraldiabetesinsipidusinchildhood
‡A
1-deamino-8-D-arginine vasopressin in the treatment of central diabetes insipidus in childhood
‡9
1
|
|
919
|
|
|
‡a
focusonbloodglucosemonitoringrelationtoglycemiccontrolanddeterminantsoffrequency
‡A
A focus on blood glucose monitoring: relation to glycemic control and determinants of frequency
‡9
1
|
|
919
|
|
|
‡a
seroepidemiologicstudyofnondiabetic1degreerelativesofiddmcases
‡A
A sero-epidemiologic study of nondiabetic first-degree relatives of IDDM cases
‡9
1
|
|
919
|
|
|
‡a
abnormalalphacellhypoglycemicrecognitioninchildrenwithinsulindependentdiabetesmellitus
‡A
Abnormal alpha cell hypoglycemic recognition in children with insulin dependent diabetes mellitus
‡9
1
|
|
919
|
|
|
‡a
abnormalalphacellhypoglycemicrecognitioninchildrenwithinsulindependentdiabetesmellitusiddm
‡A
Abnormal alpha cell hypoglycemic recognition in children with insulin dependent diabetes mellitus (IDDM)
‡9
1
|
|
919
|
|
|
‡a
abnormaltcellreactivitiesinchildhoodinflammatorydemyelinatingdiseaseandtype1diabetes
‡A
Abnormal T-cell reactivities in childhood inflammatory demyelinating disease and type 1 diabetes.
‡9
1
|
|
919
|
|
|
‡a
earlyfeedingandriskoftype1diabetesexperiencesfromthetrialtoreduceinsulindependentdiabetesmellitusinthegeneticallyatrisktrigr
‡A
Early feeding and risk of type 1 diabetes: experiences from the Trial to Reduce Insulin-dependent diabetes mellitus in the Genetically at Risk (TRIGR).
‡9
1
|
|
919
|
|
|
‡a
earlyandlate100peptideresponsesduringoralglucosetolerancetestingareoppositelypredictiveoftype1diabetesinautoantibodypositiveindividuals
‡A
Early and late C-peptide responses during oral glucose tolerance testing are oppositely predictive of type 1 diabetes in autoantibody-positive individuals
‡9
1
|
|
919
|
|
|
‡a
clusteringofprematuremortalityin1761insulindependentdiabeticsandtheirfamilymembers
‡A
Clustering of premature mortality in 1,761 insulin-dependent diabetics and their family members
‡9
1
|
|
919
|
|
|
‡a
earlyadolescentrelationshippredictorsofemergingadultoutcomesyouthwithandwithouttype1diabetes
‡A
Early adolescent relationship predictors of emerging adult outcomes: youth with and without type 1 diabetes
‡9
1
|
|
919
|
|
|
‡a
diurnalglucosedependentfluctuationsinglycosylatedhemoglobinlevelsininsulindependentdiabetes
‡A
Diurnal glucose--dependent fluctuations in glycosylated hemoglobin levels in insulin-dependent diabetes
‡9
1
|
|
919
|
|
|
‡a
characterizationofsomatostatinspecificbindinginplasmacellmembranesofhumanplacenta
‡A
Characterization of Somatostatin Specific Binding in Plasma Cell Membranes of Human Placenta
‡9
1
|
|
919
|
|
|
‡a
diseaseprogressionamong446childrenwithnewlydiagnosedtype1diabeteslocatedinscandinaviaeuropeandnorthamericaduringthelast27yr
‡A
Disease progression among 446 children with newly diagnosed type 1 diabetes located in Scandinavia, Europe, and North America during the last 27 yr
‡9
1
|
|
919
|
|
|
‡a
differencesbetweenblacksandwhitesintheepidemiologyofinsulindependentdiabetesmellitusinalleghenycountypennsylvania
‡A
Differences between blacks and whites in the epidemiology of insulin-dependent diabetes mellitus in Allegheny County, Pennsylvania
‡9
1
|
|
919
|
|
|
‡a
dietofadolescentswithandwithoutdiabetestradingcandyforpotatochips
‡A
Diet of adolescents with and without diabetes: Trading candy for potato chips?
‡9
1
|
|
919
|
|
|
‡a
ageandsexvariationsinglucosetoleranceandinsulinresponsesparallelswithcardiovascularrisk
‡A
Age and sex variations in glucose tolerance and insulin responses: parallels with cardiovascular risk
‡9
1
|
|
919
|
|
|
‡a
allcausemortalitytrendsinalargepopulationbasedcohortwithlongstandingchildhoodonsettype1diabetesthealleghenycountytype1diabetesregistry
‡A
All-cause mortality trends in a large population-based cohort with long-standing childhood-onset type 1 diabetes: the Allegheny County type 1 diabetes registry
‡9
1
|
|
919
|
|
|
‡a
analysesonpossibleheterogeneityofiddmbasedonpresenceofisletcellcytoplasmicantibodyatdiagnosis
‡A
Analyses on possible heterogeneity of IDDM based on presence of islet cell cytoplasmic antibody at diagnosis
‡9
1
|
|
919
|
|
|
‡a
antibodiestooxidizedldlandldlcontainingimmunecomplexesasriskfactorsforcoronaryarterydiseaseindiabetesmellitus
‡A
Antibodies to oxidized LDL and LDL-containing immune complexes as risk factors for coronary artery disease in diabetes mellitus
‡9
1
|
|
919
|
|
|
‡a
antibodiestooxidizedldlpredictcoronaryarterydiseaseintype1diabetesanestedcasecontrolstudyfromthepittsburghepidemiologyofdiabetescomplicationsstudy
‡A
Antibodies to oxidized LDL predict coronary artery disease in type 1 diabetes: a nested case-control study from the Pittsburgh Epidemiology of Diabetes Complications Study
‡9
1
|
|
919
|
|
|
‡a
antigenbasedtherapywithglutamicaciddecarboxylasegadvaccineinpatientswithrecentonsettype1diabetesarandomiseddoubleblindtrial
‡A
Antigen-based therapy with glutamic acid decarboxylase (GAD) vaccine in patients with recent-onset type 1 diabetes: a randomised double-blind trial
‡9
1
|
|
919
|
|
|
‡a
arepredictorsofcoronaryheartdiseaseandlowerextremityarterialdiseaseintype1diabetesthesameaprospectivestudy
‡A
Are predictors of coronary heart disease and lower-extremity arterial disease in type 1 diabetes the same? A prospective study
‡9
1
|
|
919
|
|
|
‡a
assessmentofalbusureanditsusefulnessinidentifyingiddmsubjectsatincreasedriskfordevelopingclinicaldiabeticnephropathy
‡A
Assessment of AlbuSure and its usefulness in identifying IDDM subjects at increased risk for developing clinical diabetic nephropathy
‡9
1
|
|
919
|
|
|
‡a
diabeticretinopathyinmauriacssyndromeparadoxicaldeteriorationwithimprovedmetaboliccontrol
‡A
Diabetic retinopathy in Mauriac's syndrome. Paradoxical deterioration with improved metabolic control
‡9
1
|
|
919
|
|
|
‡a
diabeticnephropathyinadolescenceappearanceduringimprovedglycemiccontrol
‡A
Diabetic nephropathy in adolescence: appearance during improved glycemic control
‡9
1
|
|
919
|
|
|
‡a
associationbetweenfamilyhistoryearlygrowthandtheriskofbetacellautoimmunityinchildrenatriskfortype1diabetes
‡A
Association between family history, early growth and the risk of beta cell autoimmunity in children at risk for type 1 diabetes
‡9
1
|
|
919
|
|
|
‡a
diabeticautonomicneuropathyandcardiovascularriskpittsburghepidemiologyofdiabetescomplicationsstudy3
‡A
Diabetic autonomic neuropathy and cardiovascular risk. Pittsburgh Epidemiology of Diabetes Complications Study III
‡9
1
|
|
919
|
|
|
‡a
diabetescomplicationsandglycemiccontrolthepittsburghprospectiveinsulindependentdiabetescohortstudystatusreportafter5yrofiddm
‡A
Diabetes complications and glycemic control. The Pittsburgh Prospective Insulin-Dependent Diabetes Cohort Study Status Report after 5 yr of IDDM
‡9
1
|
|
919
|
|
|
‡a
detectionofsymptomsbyadolescentsandyoungadultswithtype1diabetesduringexperimentalinductionofmildhypoglycemiaroleofhormonalandpsychologicalvariables
‡A
Detection of symptoms by adolescents and young adults with type 1 diabetes during experimental induction of mild hypoglycemia: role of hormonal and psychological variables.
‡9
1
|
|
919
|
|
|
‡a
choiceofurinesamplepredictiveofmicroalbuminuriainpatientswithinsulindependentdiabetesmellitus
‡A
Choice of urine sample predictive of microalbuminuria in patients with insulin-dependent diabetes mellitus
‡9
1
|
|
919
|
|
|
‡a
demonstrationofadawnphenomenoninnormaladolescents
‡A
Demonstration of a dawn phenomenon in normal adolescents
‡9
1
|
|
919
|
|
|
‡a
cytoplasmicisletcellantibodiesremainvaluableindefiningriskofprogressiontotype1diabetesinsubjectswithotherisletautoantibodies
‡A
Cytoplasmic islet cell antibodies remain valuable in defining risk of progression to type 1 diabetes in subjects with other islet autoantibodies.
‡9
1
|
|
919
|
|
|
‡a
cyclosporintherapyforpreventionandcureofiddmepidemiologicalperspectiveofbenefitsandrisks
‡A
Cyclosporin therapy for prevention and cure of IDDM. Epidemiological perspective of benefits and risks
‡9
1
|
|
919
|
|
|
‡a
cumulativeglycemicexposureandmicrovascularcomplicationsininsulindependentdiabetesmellitustheglycemicthresholdrevisited
‡A
Cumulative glycemic exposure and microvascular complications in insulin-dependent diabetes mellitus. The glycemic threshold revisited
‡9
1
|
|
919
|
|
|
‡a
crosssectionalandlongitudinalrelationshipofsodiumlithiumcountertransporttoinsulinobesityandbloodpressureinhealthyperimenopausalwomen
‡A
Cross-sectional and longitudinal relationship of sodium-lithium countertransport to insulin, obesity and blood pressure in healthy perimenopausal women
‡9
1
|
|
919
|
|
|
‡a
costimulationmodulationwithabataceptinpatientswithrecentonsettype1diabetesfollowup1yearaftercessationoftreatment
‡A
Costimulation modulation with abatacept in patients with recent-onset type 1 diabetes: follow-up 1 year after cessation of treatment
‡9
1
|
|
919
|
|
|
‡a
correlatesofinsulinantibodiesinnewlydiagnosedchildrenwithinsulindependentdiabetesbeforeinsulintherapy
‡A
Correlates of insulin antibodies in newly diagnosed children with insulin-dependent diabetes before insulin therapy
‡9
1
|
|
919
|
|
|
‡a
coronarycalciuminadultswithtype1diabetesastrongercorrelateofclinicalcoronaryarterydiseaseinmenthaninwomen
‡A
Coronary calcium in adults with type 1 diabetes: a stronger correlate of clinical coronary artery disease in men than in women
‡9
1
|
|
919
|
|
|
‡a
coronaryarterydiseaseiniddmgenderdifferencesinriskfactorsbutnotrisk
‡A
Coronary artery disease in IDDM. Gender differences in risk factors but not risk
‡9
1
|
|
919
|
|
|
‡a
contributionofdiabetesdurationbeforepubertytodevelopmentofmicrovascularcomplicationsiniddmsubjects
‡A
Contribution of diabetes duration before puberty to development of microvascular complications in IDDM subjects
‡9
1
|
|
919
|
|
|
‡a
associationsofhba1cwiththetimingof100peptideresponsesduringtheoralglucosetolerancetestatthediagnosisoftype1diabetes
‡A
Associations of HbA1c with the timing of C-peptide responses during the oral glucose tolerance test at the diagnosis of type 1 diabetes
‡9
1
|
|
919
|
|
|
‡a
condomusepregnancyandstdsinadolescentfemaleswithandwithouttype1diabetes
‡A
Condom use, pregnancy, and STDs in adolescent females with and without type 1 diabetes.
‡9
1
|
|
919
|
|
|
‡a
autoantibodiesdirectedtowardanovelia2variantproteinenhancepredictionoftype1diabetes
‡A
Autoantibodies Directed Toward a Novel IA-2 Variant Protein Enhance Prediction of Type 1 Diabetes
‡9
1
|
|
919
|
|
|
‡a
autoimmuneisletdestructioninspontaneoustype1diabetesisnotbetacellexclusive
‡A
Autoimmune islet destruction in spontaneous type 1 diabetes is not beta-cell exclusive.
‡9
1
|
|
919
|
|
|
‡a
autoimmunityandgeneticscontributetotheriskofinsulindependentdiabetesmellitusinfamiliesisletcellantibodiesandhladqheterodimers
‡A
Autoimmunity and genetics contribute to the risk of insulin-dependent diabetes mellitus in families: islet cell antibodies and HLA DQ heterodimers
‡9
1
|
|
919
|
|
|
‡a
characterizingsuddendeathanddeadinbedsyndromeintype1diabetesanalysisfrom2childhoodonsettype1diabetesregistries
‡A
Characterizing sudden death and dead-in-bed syndrome in Type 1 diabetes: analysis from two childhood-onset Type 1 diabetes registries.
‡9
1
|
|
919
|
|
|
‡a
blymphocytedepletionwithrituximabandβcellfunction2yearresults
‡A
B-lymphocyte depletion with rituximab and β-cell function: two-year results
‡9
1
|
|
919
|
|
|
‡a
comparisonofphysiologicandpharmacologicassessmentofgrowthhormonesecretion
‡A
Comparison of Physiologic and Pharmacologic Assessment of Growth Hormone Secretion
‡9
1
|
|
919
|
|
|
‡a
comparisonofadolescentswithandwithoutdiabetesonindicesofpsychosocialfunctioningfor3years
‡A
Comparison of adolescents with and without diabetes on indices of psychosocial functioning for three years
‡9
1
|
|
919
|
|
|
‡a
combinedanalysisofgad65andica512ia2autoantibodiesinorganandnonorganspecificautoimmunediseasesconfershighspecificityforinsulindependentdiabetesmellitus
‡A
Combined analysis of GAD65 and ICA512(IA-2) autoantibodies in organ and non-organ-specific autoimmune diseases confers high specificity for insulin-dependent diabetes mellitus
‡9
1
|
|
943
|
|
|
‡a
198x
‡A
1985
‡9
1
|
|
943
|
|
|
‡a
201x
‡A
2017
‡9
1
|
|
996
|
|
|
‡2
DNB|1280258624
|
|
996
|
|
|
‡2
ISNI|0000000022808677
|
|
996
|
|
|
‡2
J9U|987007315175105171
|
|
996
|
|
|
‡2
DNB|123138019
|
|
996
|
|
|
‡2
PLWABN|9810583474105606
|
|
996
|
|
|
‡2
ISNI|0000000041039092
|
|
996
|
|
|
‡2
NUKAT|n 2012110345
|
|
996
|
|
|
‡2
LC|no2015053796
|
|
996
|
|
|
‡2
NUKAT|n 2015057113
|
|
996
|
|
|
‡2
LC|no 89004666
|
|
996
|
|
|
‡2
DNB|172806089
|
|
996
|
|
|
‡2
ISNI|0000000058677197
|
|
996
|
|
|
‡2
DNB|121513270
|
|
996
|
|
|
‡2
ISNI|0000000005577483
|
|
996
|
|
|
‡2
RERO|A002982770
|
|
996
|
|
|
‡2
DNB|104222093
|
|
996
|
|
|
‡2
DNB|171937538
|
|
996
|
|
|
‡2
DNB|1050424077
|
|
996
|
|
|
‡2
BIBSYS|99059411
|
|
996
|
|
|
‡2
NUKAT|n 2004029965
|
|
996
|
|
|
‡2
ISNI|0000000382617786
|
|
996
|
|
|
‡2
DNB|115618910
|
|
996
|
|
|
‡2
ISNI|0000000019428059
|
|
996
|
|
|
‡2
ISNI|0000000021846639
|
|
996
|
|
|
‡2
LC|n 80008340
|
|
996
|
|
|
‡2
ISNI|000000007586033X
|
|
996
|
|
|
‡2
LC|no2007128610
|
|
996
|
|
|
‡2
LC|nr 95009735
|
|
996
|
|
|
‡2
J9U|987007525002305171
|
|
996
|
|
|
‡2
LC|n 81044101
|
|
996
|
|
|
‡2
ISNI|000000004350965X
|
|
996
|
|
|
‡2
DNB|133460703
|
|
996
|
|
|
‡2
DNB|131619907X
|
|
996
|
|
|
‡2
PLWABN|9810590802505606
|
|
996
|
|
|
‡2
ISNI|0000000112547255
|
|
996
|
|
|
‡2
J9U|987007405726405171
|
|
996
|
|
|
‡2
DNB|1200362152
|
|
996
|
|
|
‡2
DNB|124351174
|
|
996
|
|
|
‡2
J9U|987007332132505171
|
|
996
|
|
|
‡2
BIBSYS|90292135
|
|
996
|
|
|
‡2
DNB|135305799
|
|
996
|
|
|
‡2
NUKAT|n 2012107790
|
|
996
|
|
|
‡2
DNB|1157295509
|
|
996
|
|
|
‡2
LC|no2017073466
|
|
996
|
|
|
‡2
LC|n 2005070189
|
|
996
|
|
|
‡2
BAV|495_73745
|
|
996
|
|
|
‡2
DNB|13244688X
|
|
996
|
|
|
‡2
DNB|143951610
|
|
996
|
|
|
‡2
SUDOC|176717927
|
|
996
|
|
|
‡2
DNB|1102182745
|
|
996
|
|
|
‡2
NKC|xx0194141
|
|
996
|
|
|
‡2
LC|n 00033207
|
|
996
|
|
|
‡2
DNB|120778262
|
|
996
|
|
|
‡2
DNB|1070472352
|
|
996
|
|
|
‡2
ISNI|0000000021660674
|
|
996
|
|
|
‡2
PLWABN|9810608588105606
|
|
996
|
|
|
‡2
DNB|1279969229
|
|
996
|
|
|
‡2
DNB|1158896735
|
|
996
|
|
|
‡2
LC|n 87148496
|
|
996
|
|
|
‡2
DNB|1234605767
|
|
996
|
|
|
‡2
DNB|1247313360
|
|
996
|
|
|
‡2
DNB|1203214782
|
|
996
|
|
|
‡2
ISNI|0000000074227946
|
|
996
|
|
|
‡2
LC|n 81046372
|
|
996
|
|
|
‡2
DNB|135925983
|
|
996
|
|
|
‡2
ISNI|0000000014578875
|
|
996
|
|
|
‡2
NTA|313059276
|
|
996
|
|
|
‡2
DNB|138295565
|
|
996
|
|
|
‡2
DNB|14036546X
|
|
996
|
|
|
‡2
CAOONL|ncf10053033
|
|
996
|
|
|
‡2
CAOONL|ncf10253825
|
|
997
|
|
|
‡a
0 0 lived 0 0
‡9
1
|
